α-Synuclein Negatively Regulates Nurr1 Expression Through NF-κB-Related Mechanism

被引:27
作者
Jia, Congcong [1 ,2 ]
Qi, Hongqian [1 ,2 ]
Cheng, Cheng [1 ,2 ]
Wu, Xuefei [3 ]
Yang, Zhaofei [1 ,2 ]
Cai, Huaibin [4 ]
Chen, Sheng [5 ]
Le, Weidong [1 ,2 ]
机构
[1] Dalian Med Univ, Affiliated Hosp 1, Ctr Clin Res Neurol Dis, Dalian, Peoples R China
[2] Dalian Med Univ, Affiliated Hosp 1, Liaoning Prov Key Lab Res Pathogen Mech Neurol Di, Dalian, Peoples R China
[3] Dalian Med Univ, Coll Basic Med Sci, Dept Physiol, Liaoning Prov Key Lab Cerebral Dis, Dalian, Peoples R China
[4] NIA, Transgen Sect, Lab Neurogenet, NIH, Bethesda, MD 20892 USA
[5] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Neurol, Sch Med, Shanghai, Peoples R China
来源
FRONTIERS IN MOLECULAR NEUROSCIENCE | 2020年 / 13卷
关键词
alpha-synuclein; nuclear factor kappa B (NF-kappa B); nuclear receptor-related 1 protein (Nurr1); Parkinson's disease; dopamine; DOPAMINERGIC-NEURONS; GENE-EXPRESSION; PARKINSONS-DISEASE; RECEPTOR NURR1; TRANSCRIPTION; ACTIVATION; MUTATION; BINDING; PROTEIN;
D O I
10.3389/fnmol.2020.00064
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The nuclear receptor-related 1 protein (Nurr1) is critical for the development and survival of midbrain dopamine neurons that are predominantly affected and progressively degenerated in Parkinson's disease (PD). The expression level of Nurr1 has been proposed to be modulated by alpha-synuclein (alpha-SYN), an important pathological hallmark of PD. However, the underlying molecular mechanisms of alpha-SYN-Nurr1 interaction are still rarely explored. In this study, we investigated the effect and mechanism of alpha-SYN on the transcription level of Nurr1. Our results showed that overexpression of alpha-SYN (WT or A53T) reduced Nurr1 and its downstream gene expressions. alpha-SYN neither affected the mRNA stability nor bound with the promoter of Nurr1, but modulated the transcription activity of Nurr1 promoter region ranging from -605 bp to -418 bp, which contains the binding site of nuclear factor-kappa B (NF-kappa B). Moreover, overexpression of alpha-SYN (WT or A53T) down-regulated NF-kappa B expression level, thereby inhibiting the transcription factor activity of NF-kappa B and decreasing the binding quantity of NF-kappa B with Nurr1 promoter. These findings may give us new insights to better understand the molecular mechanisms underlying the alpha-SYN-regulated Nurr1 function, which may fascinate the investigation of dopamine neuron degeneration in PD pathogenesis.
引用
收藏
页数:9
相关论文
共 33 条
  • [1] Co-ordinate transcriptional regulation of dopamine synthesis genes by α-synuclein in human neuroblastoma cell lines
    Baptista, MJ
    O'Farrell, C
    Daya, S
    Ahmad, R
    Miller, DW
    Hardy, J
    Farrer, MJ
    Cookson, MR
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 85 (04) : 957 - 968
  • [2] Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite
    Bruning, John M.
    Wang, Yan
    Oltrabella, Francesca
    Tian, Boxue
    Kholodar, Svetlana A.
    Liu, Harrison
    Bhattacharya, Paulomi
    Guo, Su
    Holton, James M.
    Fletterick, Robert J.
    Jacobson, Matthew P.
    England, Pamela M.
    [J]. CELL CHEMICAL BIOLOGY, 2019, 26 (05): : 674 - +
  • [3] The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia
    Cao, Shuwen
    Standaert, David G.
    Harms, Ashley S.
    [J]. JOURNAL OF NEUROINFLAMMATION, 2012, 9
  • [4] NURR1 in Parkinson disease-from pathogenesis to therapeutic potential
    Decressac, Mickael
    Volakakis, Nikolaos
    Bjorklund, Anders
    Perlmann, Thomas
    [J]. NATURE REVIEWS NEUROLOGY, 2013, 9 (11) : 629 - 636
  • [5] α-Synuclein-Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons
    Decressac, Mickael
    Kadkhodaei, Banafsheh
    Mattsson, Bengt
    Laguna, Ariadna
    Perlmann, Thomas
    Bjorklund, Anders
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (163)
  • [6] Part II:: α-synuclein and its molecular pathophysiological role in neurodegenerative disease
    Dev, KK
    Hofele, K
    Barbieri, S
    Buchman, VL
    van der Putten, H
    [J]. NEUROPHARMACOLOGY, 2003, 45 (01) : 14 - 44
  • [7] Proteasomal Inhibition as a Treatment Strategy for Parkinson's Disease: The Impact of α-Synuclein on Nurr1
    Devine, Michael J.
    [J]. JOURNAL OF NEUROSCIENCE, 2012, 32 (46) : 16071 - 16073
  • [8] Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease
    Dong, Jie
    Cui, Yanhua
    Li, Song
    Le, Weidong
    [J]. CURRENT NEUROPHARMACOLOGY, 2016, 14 (04) : 339 - 355
  • [9] JASPAR 2020: update of the open-access database of transcription factor binding profiles
    Fornes, Oriol
    Castro-Mondragon, Jaime A.
    Khan, Aziz
    van der Lee, Robin
    Zhang, Xi
    Richmond, Phillip A.
    Modi, Bhavi P.
    Correard, Solenne
    Gheorghe, Marius
    Baranasic, Damir
    Santana-Garcia, Walter
    Tan, Ge
    Cheneby, Jeanne
    Ballester, Benoit
    Parcy, Francois
    Sandelin, Albin
    Lenhard, Boris
    Wasserman, Wyeth W.
    Mathelier, Anthony
    [J]. NUCLEIC ACIDS RESEARCH, 2020, 48 (D1) : D87 - D92
  • [10] A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro
    Hammond, Sean L.
    Safe, Stephen
    Tjalkens, Ronald B.
    [J]. NEUROSCIENCE LETTERS, 2015, 607 : 83 - 89